DCLK1 and cancer: Although DCLK1 is upregulated in angiogenesis and regulates chemotherapy resistance and cancer stemness by WNT signaling, knowledge of the effect of DCLK1 on hypoxia-driven immune cells, endothelial cells, blood vessels, and ECM remains limited [91].